No protective effect of the NMDA antagonist memantine in experimental spinal cord injuries

Journal of Neurotrauma

Volumn 14, Issue 1, 1997, Pages 53-61

  Von Euler, Mia ^a   Li Li, M O ^a   Whittemore, Scott ^b   Seiger, Åke ^a   Sundström, Erik ^a,c  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^c Division of Geriatric Medicine   (Sweden)

Author keywords

memantine; N methyl D aspartate receptor; neuroprotection; spinal cord injury

Indexed keywords

DIZOCILPINE; MEMANTINE; METHYLPREDNISOLONE SODIUM SUCCINATE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BINDING AFFINITY; BRAIN PROTECTION; CONTROLLED STUDY; DRUG EFFECT; DRUG RECEPTOR BINDING; FEMALE; NEUROPATHOLOGY; NONHUMAN; RAT; SPINAL CORD INJURY;

EID: 0031047121     PISSN: 08977151     EISSN: None     Source Type: Journal    
DOI: 10.1089/neu.1997.14.53     Document Type: Article

References (37)

1. ALBIN, M.S., WHITE, R.J., and LOCKE, G.E. (1965). Treatment of spinal cord trauma by selective hypothermic perfusion. Surg. Forum 16, 423-424.
2. BACKHAUSS, C., and KRIEGLSTEIN, J. (1992). Extract of kava (Piper methysticum) and its methysticin constituents protect brain tissue against ischemic damage in rodents. Eur. J. Pharmacol. 215, 265-269.
3. BERNERT, H., and TURSKI, L. (1996). Traumatic brain damage prevented by the non-N-methyl-D-aspartate antagonist 2,3-dihydroxy-6-nitro-7-sulfamoylbenzo(F)quinoxaline. Proc. Natl. Acad. Sci. U.S.A. 93, 5235-5240.
4. BORMANN, J. (1989). Memantine is a potent blocker of N-methyl-D-aspartate (NMDA) receptor channel. Eur. J. Pharmacol. 166, 591-592.
5. BRESINK, I., DANYSZ, W., PARSONS, C.G., and MUTSCHLER, E. (1995). Different binding affinities of NMDA receptor channel blockers in various brain regions-indication of NMDA receptor heterogeneity. Neuropharmacology 34, 533-540.
6. BUCHAN, A., and PULSINELLI, W.A. (1990). Hypothermia but not the N-methyl-D-aspartate antagonist, MK-801, attenuates neuronal damage in gerbils subjected to transient global ischemia. J. Neurosci. 10, 311-316.
7. CHEN, H.-S.V., PELLEGRINI, J.W., AGGRAWAL, S.K., LEI, S.Z., WARACH, S., JENSEN, F.E., and LIPTON, S.A. (1992). Open-channel block of N-methyl-D-aspartate (NMDA) responses by memantine: Therapeutic advantage against NMDA receptor-mediated neurotoxicity. J. Neurosci. 12, 4427-4436.
8. 50) of an enzymatic reaction. Biochem. Pharmacol. 22, 3099-3108.
9. ERDÖ, S.L., and SCHÄFER, M. (1991). Memantine is highly potent in protecting cortical cultures against excitotoxic cell death evoked by glutamate and N-methyl-D-aspartate. Eur. J. Pharmacol. 198, 215-217.
10. FADEN, A.I., and SIMON, R.P. (1988). A potential role for excitotoxins in the pathophysiology of spinal cord injury. Ann. Neurol. 23, 623-626.
11. FADEN, A.I., ELLISON, J.A., and NOBLE, L.J. (1990). Effects of competitive and non-competitive NMDA receptor antagonists in spinal cord injury. Eur. J. Pharmacol. 175, 165-174.
12. GALE, K., KERASIDIS, H., and WRATHALL, J.R. (1985). Spinal cord contusion in the rat: Behavioral analysis of functional neurologic impairment. Exp. Neurol. 88, 123-134.
13. GOMÉZ-PINILLA, F., TRAM, H., COTMAN, C., and NIETOSAMPEDRO, M. (1989). Neuroprotective effect of MK-801 and U-50488H after contusive spinal cord injury. Exp. Neurol. 104, 118-124.
14. HAO, J.-X., WATSON, B.D., XU, X.-J., WIESENFELDHALLIN, Z., SEIGER, Å., and SUNDSTRÖM, E. (1992). Protective effect of the NMDA antagonist MK-801 on photochemically induced spinal lesions in the rat. Exp. Neurol. 118, 143-152.
15. HAYES, R.L., JENKINS, L., LYETH, B., BALSTER, R.L., ROBINSON, S.E., MILLER, L.P., CLIFTON, G.L., and YOUNG, H.F. (1988). Pretreatment with phencyclidine, an N-methyl-D-aspartate receptor antagonist, attenuates long-term behavioral deficits in the rat produced by traumatic brain injury. J. Neurotrauma 5, 287-302.
16. HERRERO, J.F., HEADLEY, P.M., and PARSONS, C.G. (1994). Memantine selectively depresses NMDA receptor-mediated responses of rat spinal neurones in vivo. Neurosci. Lett. 165, 37-40.
17. KOCHAR, A., ZIVIN, J.A., LYDEN, P.D., and MAZZARELLA, V. (1988). Glutamate antagonist therapy reduces neurologic deficits produced by focal central nervous system ischemia. Arch. Neurol. 45, 148-153.
18. 3H]MK-801 at therapeutic concentrations in postmortem human frontal cortex. Eur. J. Pharmacol. 166, 589-590.
19. LIU, D., THANGNIPON, W., and MCADOO, D.J. (1991). Excitatory amino acids rise to toxic levels upon impact injury to the rat spinal cord. Brain Res. 547, 344-348.
20. MINAMISAWA, H., MELLERGÅRD, P., SMITH, M.-L., BENGTSSON, F., THEANDER, S., BORIS-MÖLLER, F., and SIESJÖ, B.K. (1990). Preservation of brain temperature during ischemia in rats. Stroke 21, 758-764.
21. NIETO-SAMPEDRO, M., BAILÓN, C., RIVAS, F., and MORENO, M.T. (1991). Sex differences in the effect of MK-801 on normal and spinal cord injured rats. Rest. Neurol. Neurosci. 2, 175-179.
22. PARSONS, C.G., GRUNER, R., ROZENTAL, J., MILLAR, J., and LODGE, D. (1993). Patch clamp studies on the kinetics and selectivity of N-methyl-D-aspartate receptor antagonism by memantine (1-amino-3,5-dimethyl-adamantan). Neuropharmacology 32, 1337-1350.
23. PENCALET, P., OHANNA, F., POULAT, P., KAMENKA, J.-M., and PRIVAT, A. (1993). Thienylphencyclidine protection for the spinal cord of adult rats against extension of lesions secondary to a photochemical injury. J. Neurosurg. 78, 603-609.
24. RIVLIN, A.S., and TATOR, C.S. (1977). Objective clinical assessment of motor function after experimental spinal cord injury in the rat. J. Neurosurg. 47, 577-581.
25. RIVLIN, A.S., and TATOR, C.S. (1978). Effect of duration of acute spinal cord compression in a new acute cord injury model in the rat. Surg. Neurol. 10, 39-43.
26. SEIF EL NASR, M., PERUCHE, B., ROßBERG, C., MENNEL, H.-D., and KRIEGLSTEIN, J. (1990). Neuroprotective effect of memantine demonstrated in vivo and in vitro. Eur. J. Pharmacol. 185, 19-24.
27. SHEARDOWN, M.J., NIELSEN, E.Ø., HANSEN, A.J., JACOBSEN, P., and HONORÉ, P. (1990). 2,3-dihydroxy-6-nitro-7-sulfamoyl-benzo(F)quinoxaline: A neuroprotectant for cerebral ischemia. Science 247, 571-574.
28. SIMON, R.P., SWAN, J.H., GRIFFITHS, T., and MELDRUM, B.S. (1984). Blockade of N-methyl-D-aspartate receptors may protect against ischemic damage in the brain. Science 226, 850-852.
29. SIMPSON, R.K., JR., ROBERTSON, C.S., and GOODMAN, J.C. (1990). Spinal cord ischemia-induced elevation of amino acids: Extracellular measurements with microdialysis. Neurochem. Res. 15, 635-639.
30. 3H]MK-801 binding in the rat spinal cord. Eur. J. Pharmacol. 307, 347-353.
31. TARLOV, I.M., and KLINGER, H. (1954). Spinal cord compression studies II. Time limits for recovery after acute compression in dogs. A.M.A. Archiv. Neurol. Psych. 71, 271-290.
32. VON EULER, M., SEIGER, Å., HOLMBERG, L., and SUNDSTRÖM, E. (1994). NBQX, a competitive non-NMDA antagonist reduces degeneration due to focal spinal cord ischemia. Exp. Neurol. 129, 163-168.
33. VON EULER, M., ÅKESSON, E., SAMUELSSON, E.-B., SEIGER, Å., and SUNDSTRÖM, E. (1996). Motor performance score: a new algorithm for accurate behavioral testing of spinal cord injury in rats. Exp. Neurol. 137, 242-254.
34. WATSON, B.D., HOLETS, V.R., PRADO, R., and BUNGE, M.B. (1993). Laser-driven photochemical induction of spinal cord injury in the rat: Methodology, histopathology, and applications. Neuroprotocols 3, 3-15.
35. WRATHALL, J.R., CHOINIERE, D., and TENG, Y.D. (1994). Dose-dependent reduction of tissue loss and functional impairment after spinal cord trauma with the AMPA/kainate antagonist NBQX. J. Neurosci. 14, 6598-6607.
36. WRATHALL, J.R., TENG, Y.D., and CHOINIERE, D. (1996). Amelioration of functional deficits from spinal cord trauma with systemically administered NBQX, and antagonist of non-N-methyl-D-aspartate receptors. Exp. Neurol. 137, 119-126.
37. YUM, S.W., and FADEN, A.I. (1990). Comparison of the neuroprotective effects of the N-methyl-D-aspartate antagonist MK-801 and the opiate-receptor antagonist nalmefene in experimental spinal cord ischemia. Arch. Neurol. 47, 277-281.